35
Journal of CyberTherapy & Rehabilitation
S p r i n g 2 0 1 2 , Vo l u m e 5 , I s s u e 1
© Vi r t u a l R e a l i t y M e d i c a l I n s t i t u t e
VIrtuAl rEAlIty ExPosurE thErAPy VErsus cognItIVE BEhAVIor thErAPy for PAnIc dIsordEr wIth
AgorAPhoBIA: A rAndomIzEd comPArIson study
Antoine Pelissolo1, Mohammed Zaoui2, Gloria Aguayo3, Sai Nan Yao4, Sylvain Roche5, Rene Ecochard5, François Gueyffier6,
Charles Pull3, Alain Berthoz2, Roland Jouvent1 and Jean Cottraux4
our objective was to compare the effects of Virtual reality exposure therapy (VrEt), cognitive behavior therapy (cBt),
and a waitlist control condition in patients with panic disorder with agoraphobia (PdA). ninety two out-patients were initially randomized in three arms, 29 treated with VrEt, 31 with cBt, and 32 assigned to the waitlist. At the end of a 12week period, the patients assigned to the waitlist were re-randomized in VrEt or cBt groups. no between-group
significant differences appeared at the end of the first phase, however a lower responder rate was observed in the waitlist
group. After the second randomization, response rates were not different in the VrEt and cBt groups (respectively 38.7%
and 48.5%; p=0.46). during the 9-month follow-up period, the response rates remained stable without differences between
groups. thus, VrEt seems to be an effective treatment for PdA with short-term and long-term therapeutic results equivalent to those obtained with cBt.
Keywords: Agoraphobia, cognitive Behavior therapy, Panic disorder, Virtual reality, randomized controlled trial
IntroductIon
Panic disorder with agoraphobia (PDA) is a chronic and recurrent psychiatric illness with a lifetime prevalence of about 2%
in Europe and a well-known negative impact on the quality of
life of suffering subjects (Alonso et al., 2004; Candilis et al.,
1999; Goodwin et al., 2005). Drug treatments (specific antidepressants) and cognitive behavior therapy (CBT) are recognized
as effective treatments with response rates varying between 40
and 80% according to studies and measures (Mitte, 2005; Otto
& Deveney, 2005).
Virtual Reality exposure therapy (VRET), using real-time computer graphics, body tracking devices, visual displays and other
sensory input systems, has been developed and proposed as an
alternative therapeutic method useful in psychiatric illnesses,
especially anxiety disorders (Gorini & Riva, 2008; Pull, 2005;
Riva, 2008; de Carvalho, Freire, & Nardi, 2010). VRET is based
on the gradual presentation of phobic stimuli to the patient via
a computer-generated virtual environment that is synchronized
with head and body motion (Wiederhold & Wiederhold, 2005).
This desensitization through virtual immersion has been successfully used in most anxiety disorders (Coelho, Waters, Hine,
& Wallis, 2009; Gorini & Riva, 2008; Pull, 2005). VRET may
have some advantages when compared to standard exposure
(Côté & Bouchard, 2008) as it takes place in the privacy of the
therapist’s office, can be repeated or prolonged easily, is less
time-consuming for the therapist and more acceptable by the
patients (Garcia-Palacios, Botella, Hoffman, & Fabregat, 2007;
Garcia-Palacios, Hoffman, See, Tsai, & Botella, 2001).
Two meta-analyses of VRET in anxiety disorders have been
published (Parsons & Rizzo, 2008; Powers & Emmelkamp,
2008). Both showed marked positive effects of VRET, with
mean effect sizes of 0.95 and 1.11 on anxiety measures, which
were equal or even superior to those of in vivo exposure techniques. Nevertheless, all these studies were conducted on small
samples and a limited numbers of subjects: 13 trials (n=397)
(Powers & Emmelkamp, 2008) and 21 trials (n=300) (Parsons
& Rizzo, 2008).
To date, there is only limited evidence for VRET use in PDA.
Case studies have been reported (Jang, Ku, Shin, Choi, & Kim,
2000; Wiederhold & Wiederhold, 2005). North et al (North,
North, & Coble, 1996) showed the efficacy of VRT in 30 agoraphobic students versus a non-treated control group of the same
size. Vincelli et al. (Vincelli et al., 2003) developed a specific
Corresponding Author:
Antoine Pelissolo, Service de psychiatrie adulte, Hôpital Pitié-Salpêtrière, 75651 Paris Cedex 13, France; Tel : +33 1 42 16 28 94; Fax : +33 1 42 16 18 26; E-mail :
antoine.pelissolo@upmc.fr
Department of psychiatry, Hôpital Pitié-Salpêtrière, AP-HP, CNRS USR 3246, Paris, France
Laboratoire de physiologie de la perception et de l'action, Collège de France, Paris, France
Department of Neurosciences, Centre Hospitalier de Luxembourg et Centre de Recherche Public Santé, Luxembourg
4
Anxiety disorder unit, Hôpital Neurologique, Lyon, France
5
Service de Biostatistique Hospices Civils de Lyon, Laboratoire de Biostatistique-Santé, UMR 5558, CNRS, Université Claude Bernard Lyon 1, Lyon, France
6
Centre d'investigation clinique de Lyon, Hôpital Louis Pradel, Bron, France
1
2
3
36
VRET program for panic disorder and agoraphobia named the
experiential-cognitive therapy (ExCT): a package integrating a
CBT program with four VR environments (elevator, supermarket, subway and a large open square). A preliminary investigation randomly allocated 12 consecutive patients to ExCT (eight
sessions), CBT (12 sessions), and a waitlist (Vincelli et al.,
2003). Both CBT and ExCT significantly reduced the number
of panic attacks. Another study was conducted by the same
group, comparing four sessions of ExCT to 12 sessions of CBT
in two samples of 20 patients each (Choi et al., 2005). Results
were similar in post-test assessments, but long-term effectiveness of ExCT was relatively inferior to standard CBT. Botella
et al. (Botella et al., 2007) reported a controlled study comparing
VRET and CBT programs, each including nine weekly sessions,
in panic disorder with or without agoraphobia. In post-treatment
and follow-up assessments nine months later, VRET and CBT
showed the same therapeutic results both being significantly superior to those obtained in the waitlist group. However this
study was conducted on a relatively small sample size (12 subjects per group).
VRET vs. CBT for PDA
ication, with the exception of low doses hypnotics, and could not
receive psychotherapy during the study.
After the first evaluation, subjects were randomized either to
VRET (12 sessions), CBT (12 sessions) or a waitlist control
condition for three months (see the flow chart of the study, Figure 1). An assessment was done at the end of this first threemonth period to compare the three groups. Then, the waitlist
patients were re-randomized into VRET or CBT groups for
three months of treatment (12 sessions). Hence, the whole sample was analyzed at three months and nine months after treatment. Patients received a two-page information leaflet about the
trial and signed an informed consent. An ethic committee approved the protocol. Randomization was kept secret and delivered by the biostatistics department of the CHU of Lyon through
a phone call to the secretary of each center.
A recent study showed that a computer simulation of a simple
3-D computer animation of a short bus trip, from a first person
perspective, may induce anxiety, and electrodermal and respiratory alterations in patients with PDA (Freire, De Carvalho,
Joffily, Zin, & Nardi, 2010). The use of VRET in PDA is also
encouraged by the knowledge of the role of vestibular dysfunctions in anxiety and by the potent impact of VR exposure on
this phenomenon (Jacob, Whitney, Detweiler-Shostak, & Furman, 2001; Redfern, Furman, & Jacob, 2007; Viaud-Delmon,
Ivanenko, Berthoz, & Jouvent, 2000; Viaud-Delmon, Warusfel,
Seguelas, Rio, & Jouvent, 2006). These data need to be completed with a controlled research designed to clarify the process
and outcome of “pure” CBT and “pure” VRET in PDA. In the
present study, our primary objective was to compare pure VRET
and a standard CBT program on a short- and long-term period.
Our secondary objective was to compare both therapies with the
absence of treatment (waitlist) on a short-term scale.
suBjEcts And dEsIgn
The sample was made up of outpatients referred to three centers
for specialized treatment in Lyon, Paris, and Luxembourg university hospitals. They were screened by the principal investigator
of each center using a structured interview based upon the DSM4 (American Psychiatric Association, 1996), the MINI (Lecrubier
et al., 1997), and several anxiety and depression scales. To be included, subjects had to meet the DSM-IV (American Psychiatric
Association, 1996) criteria for PDA. Patients with current major
depression, or a score greater than 18 on the Hamilton rating scale
for depression (Hamilton, 1960) at the screening visit were excluded. Patients with bipolar disorder, schizophrenia or other psychotic disorders, alcoholism, or street drugs use were not eligible.
A history of CBT for PDA, or a current psychotherapy, was also
an exclusionary factor. Patients who had received treatment with
antidepressants, neuroleptics, anxiolytics or mood stabilizers
within the two weeks preceding the entry were also excluded. Eligible patients were not allowed to take any psychotropic med-
Figure 1. Study Flow chart. Bold numbers are the groups
taken into account in the two main analyzes (M3 and M3’),
and gray boxes indicate the total final population after the second randomization (n=87). Seven subjects initially randomized in the WL group had no assessment at M3 owing to
availability problems, but continued the study (random 2).
trEAtmEnt
Both treatments comprised 12 one-hour therapeutic sessions and
were applied by the same pool of therapists to control for the
therapist effect. The therapists were post-graduate psychologists
or psychiatrists, had practiced CBT for at least five years, and
had an intensive training in VRET before starting the study.
JCR
Pelissolo et al.
cBt mEthods
Cognitive and behavior methods used were those classically recommended for PDA (Cottraux et al., 1995; Landon & Barlow,
2004), and were highly structured and reproducible. Detailed
manuals with guidelines for each session and checklists of the
techniques were provided to the therapists and information
sheets were given to the patient.
The treatment aimed at reducing both avoidant agoraphobic behavior, and the frequency of panic attacks. Session 1 comprised
functional analysis of the relationships between emotions, behavior and cognition, and relaxation teaching. Patients received
written information about panic attacks and agoraphobia, and a
tape-recorded relaxation program. They were advised to practice
relaxation 10 minutes every day. Cognitive and behavioral components were implemented from session 2 to 12. The cognitive
component used respiratory control with provoked hyperventilation and cognitive restructuring. The subjects were taught to
reattribute their symptoms to hyperventilation and/or tachycardia induced by stressful stimuli. Prolonged exposure in imagination to anxiety provoking scenes and interoceptive exposure
to anxiety-related physical sensations were used. Misinterpretations of bodily sensations are discussed in a Socratic manner.
A further step was the elicitation and disputing of automatic
negative thoughts (e.g., becoming crazy or having a heart attack)
and danger schemata. Questioning of automatic catastrophic
thoughts and basic danger schemata were maintained outside
the sessions through a daily five-column recording form discussed with the therapist. The behavioral component consisted
of graduated exposure tasks agreed on by the therapists and patients and evaluated with a behavioral avoidance test form.
Homework completion was discussed and cognitive techniques
were implemented to facilitate subsequent exposure. During the
last session, patients were advised to generalize these techniques
to any situation that triggers anxiety.
VIrtuAl rEAlIty ExPosurE thErAPy
The VRET program included 12 sessions using virtual environments developed specifically for this research at the Collège de
France (Paris, France) institute. The choice of 12 environments
was made by a panel of four experts in CBT for anxiety disorders taking into account the Fear Questionnaire ratings of panic
with agoraphobia patients, and their clinical experience: subway
scenes; tunnels (walking); elevator and tunnels; shopping in a
supermarket; car driving on a road in a lonely countryside or
near a ravine; travelling on a plane; entering and sitting in a
movie theatre; car driving in a lonely town; car driving in a tunnel and stopped by an accident; travelling by bus in a lonely
town; being caught in a sensorial conflict (derealization inducing VRET scenario); and street scenes and crowded subways.
For example, the subway scenes included navigating in the stations’ tunnels, a subway ride and a moving train (Figure 2a and
2b). According to the subjects’ anxiety level, the tasks gradually
included walking in the station, getting on the ride, staying in
the train while it’s at a stop, and finally riding for one or more
stops. In the supermarket scene (Figure 2c), the subject was supposed to walk progressively in the shop, look at various items
JCR
37
in the shelves, and when possible checking out at the cash register. In all the scenarios, the subject had the ability and was encouraged to explore visually the scene all around him in order
to create an immersion effect and to enhance presence in the
virtual world.
Figure 2. Captures of virtual
scenes used in the VERT program, for exposure to a subway context (2a and 2b;
shown at top) or a supermarket (2c; shown left).
All VR scenes were presented through a head mounted display
(HMD) which provided a 60° diagonal field of view (Kaiser Pro
view 60™), tracked head movement and was connected to a PC
running the VR program developed with Virtools software.
In the first session, the patient was familiarized with the technique and gave four ratings while he or she was confronted
briefly with the images of each of the 12 scenarios:
- Does the scenario represent a significant problem?
- Rating on the 0-100 Subjective Unit of Disturbance (SUD) the
level of anxiety that would be felt in real life.
- Rating on the SUD the level of anxiety created by the VR images.
- Classification of the 12 scenarios along a hierarchy (fear thermometer): from the less disturbing (=1) to the most disturbing
(=12). This allowed a progressive immersion into more and
more fearsome scenarios.
The therapists conducted the computer program while taking
into account the verbal and non-verbal reactions of the patients.
Some patients, familiar with computer management, were able
to carry out the navigation into VR on their own. Each scenario
was of graded complexity according to the general difficulties
encountered in agoraphobia. The therapists interacted verbally
with the patient to enhance the illusion of presence. VRET was
presented in blocks of 10 minutes. Patients received the general
instruction to expose themselves in real-life situations, but had
no formal written and structured exposure homework whereas
the CBT group subjects did. They were informed that the therapy included only the VRET sessions and that this method could
VRET vs. CBT for PDA
38
be effective to treat their disorder. Detailed manuals with guidelines for each
session and checklist of the techniques
were provided to the therapists and information sheets were given to the patient.
mEAsurEs
In order to assess the impact of the intervention on the phobic symptoms, all patients completed the Fear Questionnaire
(FQ) (Marks & Mathews, 1982) at baseline and at each visit. The other phobia
measures were the Panic Disorder Severity Scale (PDSS) (Shear, Rucci et al.,
2001), the Chambless Agoraphobic Cognitions (CAS) scale (Chambless, Caputo,
Bright, & Gallagher, 1984), and the
Panic, Phobia and Generalized Anxiety
Scale (PPGAS) (Cottraux, Bouvard, &
Légeron, 1985). Anxiety and depression
were assessed through the State and Trait
Anxiety questionnaire (STAI) (Spielberger, 1983), the Hamilton Anxiety Rating Scale (HARS) (Hamilton, 1959), and
the 21-item Beck Depression Inventory
(Beck, Steer, & Garbin, 1988). The Sheehan Disability Scale (SDS) (Sheehan,
Harnett-Sheehan, & Raj, 1996) was also
used at baseline and at each visit, as well
as the Global Assessment of Functioning
scale (GAF) (American Psychiatric Association, 1996) the Dissociative Experience Scale (DES) (Bernstein & Putnam,
1986) and the Work and Social Adjustment scale (WSA) (Mataix-Cols et al.,
2005). At the first therapeutic session
only, both the therapist and the patient
filled out the Expectancies Rating Scale
(ERS), rating the expectancies of improvement from zero to eight; the higher
the score the worse the expectations of
improvement. French validated versions
of all the scales were used (Bouvard &
Cottraux, 2005). At the end of the treatment, the Therapeutic Relationship Evaluation Scales (TRES) were filled in (the
therapists evaluated the patients and the
patients their therapists). These scales
(Cottraux et al., 1995; Hoogduin, De
Haan, & Schaap, 1989) consisted of 12
pairs of bipolar adjectives presented ranging from one (agreeable) to six (disagreeable). The higher the scores, the less
favorably the relationship was evaluated.
stAtIstIcAl AnAlysEs
Values were expressed as mean and stan-
dard deviation (SD) or frequency and
percentage. For socio-demographic and
clinical scales, baseline comparisons of
CBT, VRET and WL groups were done
with Fisher’s exact test for categorical
variables and with Kruskal-Wallis test for
dimensional variables. The response criterion was a 50% or more decrease of the
FQ agoraphobia sub-score between baseline and post-treatment visits. The three
groups were compared on this response
rate at M3, and subsequently the two
groups three months and nine months
after treatment. The response rates were
also compared using the Fisher’s exact
test, and the course of response rates over
time in VRET and CBT were compared
using two-level hierarchic models: logistic regressions with random intercepts.
Secondary outcome criteria were FQ and
other scales’ means comparison between
VRET and CBT groups at M3, M6 and
M12 with the Kruskall-Wallis test. All
statistical analyses performed with SAS
software Version 9.1.3., p < 0.05, were
considered statistically significant for all
tests (two-tailed).
rEsults
Ninety two outpatients (30 males and 62
females) were randomized in three arms:
29 in VRET, 31 in CBT, and 32 in the
waitlist (WL) group (see Figure 1). At the
end of the first 12-week period (M3), 27
patients from the WL group were randomized in the two treatment arms: 14 in
the VRET group, and 13 in the CBT
group (five subjects stopped the trial before the second randomization). After
three months of treatment (M3’), 33
Table 1
Baseline Characteristics of the Total Sample and of the Three Treatment Groups (n=92)
FQ=Fear Questionnaire; PDSS=Panic Disorder Severity Scale; HARS=Hamilton Anxiety Rating
Scale; SDS=Sheehan Disability Scale; GAF=Global Assessment of Functioning
JCR
Pelissolo et al.
39
Table 2
Mean Scores (and SD) of Anxiety and Other Scales in VRET and CBT Groups at the Four Visits of the Study (n=87)
FQ=Fear Questionnaire; PDSS=Panic Disorder Severity Scale; CAS=Chambless Agoraphobic Cognitions; STAI= State and Trait Anxiety questionnaire ; HARS=Hamilton Anxiety Rating Scale; BDI=21-item Beck Depression Inventory; DES=Dissociative Experience Scale; PPGAS=Panic,
Phobia and Generalized Anxiety Scale; WSA=Work and Social Adjustment Scale; SDS=Sheehan Disability Scale; TRES=Therapeutic Relationship
Evaluation Scales; ERS= Expectancies Rating Scale
VRET subjects were compared with 34 CBT subjects, and then
27 versus 30 at M6, and 23 versus 28 at M12.
Demographic and baseline clinical characteristics of the three
groups found no significant between-group differences (see
Table 1). The mean PDSS and FQ scores indicated relatively
severe disorders. The mean scores of the ERS-therapist were
significantly more pessimistic in the VRET group than in CBT
(p=0.01), while ERS-patient scores were not different.
At M3, no between-group significant difference appeared on the
response criterion even if a lower responder rate was observed
in the WL group: 35% versus 45.8% in the CBT group and
42.1% in the VRET group (p=0.77). At M3’, no different response rates were observed between VRET and CBT groups,
respectively 38.7% and 48.5% (p=0.46). During follow-up, no
difference emerged between both groups concerning response
rates at M6 (VRET 44% versus CBT 56.7%; p=0.42) and M12
JCR
visits (VRET 47.6% versus CBT 60.7%; p=0.40), and the response rates remained stable or tended to slightly increase. In
the two-level hierarchic mixed model, with visits (M3’, M6,
M12) and visit deviations (months) in level 1, and group (VRET
versus CBT) in level 2, no difference appeared in the response
rates between both groups, taking into account the visit x groups
interactions (OR=0.58; 0.21-1.61) or not (OR=0.58;0.21-1.62).
The mean Agoraphobia FQ sub-scores showed similar courses
in both groups, with a decrease between M0 and M3’ and a stability between M3’ and M12, without any statistical difference
during any visit (see Table 2). The mean of other scales’ scores
at each visit are presented in Table 2, which shows no significant
difference between the VRET and CBT final groups after the
second randomization, except for FQ disability sub-score at M6
(p=0,05), for Phobia 1 sub-score of the PPGAS scale also at M6
(p=0.04), and for ERS-therapist score (p=.0001), all measures
being higher in the VRET group.
40
dIscussIon
The main result is the equivalent effect obtained with VRET
and CBT in post-treatment assessment and during the ninemonth follow-up. This is the first report of a controlled comparative trial of pure VRET in PDA conducted on a sample of more
than 80 patients. Previous studies were open or controlled but
with smaller sample sizes (Botella et al., 2007; Choi et al., 2005;
North et al., 1996; Price & Anderson, 2007; Vincelli et al., 2003;
Wiederhold & Wiederhold, 2005).
Response rates obtained in both active groups (45.8% for CBT
and 42.1% for VRET at M3), using a relatively stringent criteria
of a reduction of 50% or more on the FQ agoraphobia sub-scale,
were satisfying and in accordance with those observed in reference studies for CBT. For example, in the Barlow et al. (Barlow,
Gorman, Shear, & Woods, 2000) study on panic disorder, while
using the same type of treatment methods, 48.7% of the patients
receiving CBT alone were responders. However, we could not
find a significant difference between both active groups and the
WL control group. This unusual result may be partially explained by a lack of statistical power, due to unexpected high
attrition rates (see below). Another explanation could be the relatively elevated response rate obtained in the WL group (35%),
which could be related to therapeutic expectancies in either
treatment. This was higher than the 21.7% obtained in the Barlow et al. (Barlow et al., 2000) study in the placebo group. The
reasons for this phenomenon are unclear. Our sample exhibited
a severe intensity of agoraphobia and panic: mean baseline
PDSS score of 18.2, compared to about 12-13 in the Barlow et
al. (Barlow et al., 2000) and Shear et al. (Shear, Houck, Greeno,
& Masters, 2001) studies, with similar trends for FQ scores
(Ost, Thulin, & Ramnero, 2004). Methodological factors should
probably be implicated in the high response rates obtained in
our control group and in the lack of statistical difference between active and WL group results. The choice of the response
criteria can be one of the critical methodological factors as
shown in the Barlow et al. (Barlow et al., 2000) study in which
both imipramine and CBT were significantly superior to placebo
for the acute treatment phase as assessed by the PDSS (with a
21.7% placebo response rate), but were not significantly different on the Clinical Global Impression scale (response rate
37.5%). The FQ-based outcome criteria chosen in our study is,
however, one of the more widely used in studies of CBT in agoraphobia (Bandelow, Seidler-Brandler, Becker, Wedekind, &
Ruther, 2007; Ost et al., 2004; Roy-Byrne et al., 2005; Shear,
Houck et al., 2001; Vincelli et al., 2003).
The main limitation of this study is the elevated attrition rate
during the trial (27.2%) although not exceptional; in a metaanalysis of therapeutic studies on panic disorder, Mitte found
mean drop-out rates of 15.1% ± 12.8 for CBT trials, and of
20.4% ± 15.3 for pharmacotherapy trials (Mitte, 2005). Despite
the relatively important sample size at inclusion (n=92), the final
comparisons concerned two groups of restricted size (33 versus
34 subjects at three months after treatment). This high attrition
rate limits the statistical power of the analyses. However, the
numbers of missing subjects were about the same in CBT and
VRET vs. CBT for PDA
VRET groups, respectively 22.7% and 23.2%, resulting in wellbalanced final groups. The reasons for dropping out seemed unrelated to the randomly attributed treatment and beliefs in the
effectiveness of VRT or CBT. An explanation might be the high
severity of the majority of our patients compared to similar studies (Barlow et al., 2000; Shear, Houck et al., 2001). In France
and Luxembourg the patients referred to university hospitals are
generally severe cases.
The follow-up assessment of efficacy nine months after the end
of the treatment showed that the response rates were maintained
in both groups throughout this long-term period. The therapeutic
effect size was stable with a mean reduction of about 50% of
the FQ agoraphobia sub-score and of the PDSS score in comparison with values at inclusion (Table 2). This observation is
of importance as agoraphobia and panic disorder are known to
be chronic disorders with a natural course lasting many years
according to epidemiological studies (Goodwin et al., 2005).
The long-term efficacy of CBT has been well established in
these conditions unlike what is generally observed after drug
treatment ending (Furukawa, Watanabe, & Churchill, 2007).
The fact that the same stable therapeutic effects were obtained
with VRET is an asset considering the brevity (12 weeks) of the
program. To date, only a few studies of VRET application in
psychiatric disorders have shown stable outcomes on a comparable follow-up length (Pull, 2005).
Although not significant for primary outcome variables, there
is a trend towards a slight superiority of CBT on several secondary measures when compared with VRET (see Table 2). Significant differences were observed at M6 on the FQ disturbance
sub-score and PPGAS phobia scale. However, the levels of significance were low and disappeared after corrections for multiple comparisons. This finding is clearly at variance with a
meta-analysis comparing VRET and CBT in anxiety disorders
and concludes that VRET was “slightly, but significantly, more
effective than exposure in vivo, the gold standard in the field”
(Powers & Emmelkamp, 2008). Nevertheless, some limitations
to VRET efficacy could exist in our program and some technical
or psychotherapeutic components could be optimized. An important issue in this domain is to ascertain whether the VRET
program should contain only pure VR exposure without any
other therapeutic component such as relaxation, cognitive restructuring, and exposure instructions, or if a combination could
be more efficient as suggested by some positive results obtained
through combined CBT-VRET programs for panic disorder
(Vincelli et al., 2003). This issue merges with the more general
question, which is unresolved to this date, about the decisive
therapeutic elements of CBT in anxiety disorders (Barlow &
Allen, 2004).
The phenomenon called illusion of presence (the feeling of
being in an environment although virtual) has been shown to be
highly variable and unpredictable among subjects (Draper,
Kaber, & Usher, 1999; Price & Anderson, 2007; Riva, 2008;
Robillard, Bouchard, Fournier, & Renaud, 2003). We initially
planned to measure this dimension during the VRET sessions,
JCR
Pelissolo et al.
but too much data was missing. This point needs to be explored
in future research.
Another factor explaining the slight superiority of CBT to
VRET could be the more pessimistic expectancies of the therapists regarding VRET compared with CBT, which was statistically significant. A recent study comparing VRET and CBT in
fear of flying showed that higher positive expectancies can predict a better acute therapeutic response (Price, Anderson, Henrich, & Rothbaum, 2008). However, only the expectancies of
the patients were measured in that study.
Other parameters may mediate the therapeutic response to
VRET. For example, Côté and Bouchard (Côté & Bouchard,
2009) showed that changes in perceived self-efficacy and dysfunctional beliefs were the best predictors of change in general
outcome of VRET for arachnophobia.
On a wider perspective, the place of VRET in PDA treatment
still needs clarification. Some advantages of this method have
been underlined: acceptability, confidentiality, feasibility for
some exposures such as driving or flying, and time-consumption
for the therapist, etc. (Côté & Bouchard, 2008). Another therapeutic interest may be the association of VRET with cognitive
enhancers, such as d-cycloserine, especially in anxiety disorders
(Meyerbröker & Emmelkamp, 2010). However, two important
aspects could for the moment limit its use when compared to
CBT: an insufficient knowledge of its specific efficacy on the
various symptoms and forms of PDA and the cost of the equipment. The complete apparatus to perform VRET costs at least
rEfErEncEs
Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R.,
Brugha, T. S., Bryson, H., et al. (2004). Prevalence of
mental disorders in Europe: results from the European
Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Supplementum, 420, 21-27.
41
about 3000 dollars (with a need for a specific long-term maintenance), which is accessible for specialized and research centers, but not for front line therapists.
From a technical point of view, we used a HMD with relatively
poor field of vision (60°). It was, at the time of the research, the
best compromise between 3-D glasses and auto-stereo screens
in order to create a good immersion effect, limit distractors in
the field of vision, and be spatially and materially compatible
with a hospital context. Recent progress in HMD devices (e.g.,
larger field of vision) provide higher immersion effects and,
probably, would enhance some exposure and therapeutic effects.
In conclusion, our primary objective was to show that “pure”
VRET could be effective to treat PDA. This study, despite some
limitations, suggests that the acute and long-term efficacy of
“pure” VRET and “classical” CBT are similar in PDA. Further
studies should now determine the optimal combination of the
therapeutic components belonging to each method in order to
optimize the outcomes.
Acknowledgements
This study has been supported by a grant from the French ministry of health: PHRC 2002 # 02-106, Hospices Civils de Lyon,
and by a grant of the Luxembourg Hospital. We thank Chantal
De Mey Guillard, Annie Duinat, Marie-Claire Erpelding-Pull,
Frédéric Fanget. Virginie Genouilhac, Evelyne Mollard, Panagiota Panagiotaki, Manuela Tomba, Lidwine Wouters, and Feryel Znaidi for their participation to the study, and Albert
Moukheiber for proofreading the manuscript.
(2000). Cognitive-behavioral therapy, imipramine, or
their combination for panic disorder: A randomized
controlled trial. Journal of the American Medical Association, 283, 2529-2536.
Beck, A., Steer, R., & Garbin, M. (1988). Psychometric properties
of the Beck depression inventory: twenty-five years of
research. Clinical Psychological Review, 8, 77-100.
American Psychiatric Association. (1996). Diagnostic and Statistical Manual of Mental Disorders, fourth edition.
Washington DC:1994. Washington: American Psychiatric Press.
Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability, and validity of a dissociation scale. Journal of
Nervous and Mental Disease, 174, 727-735.
Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D.,
& Ruther, E. (2007). Meta-analysis of randomized
controlled comparisons of psychopharmacological
and psychological treatments for anxiety disorders.
World Journal of Biological Psychiatry, 8, 175-187.
Botella, C., Villa, H., Garcia-Palacios, A., Banos, R. M., Quero,
S., Alcaniz, M., et al. (2007). Virtual reality exposure
in the treatment of panic disorder and agoraphobia: A
controlled study. Clinical Psychology & Psychotherapy, 14, 164-175.
Barlow, D. H., & Allen, L. B. (2004). Scientific basis of psychological treatments for anxiety disorder. In J. M.
Gorman (Ed.), Fear and anxiety (pp. 171-191). Washington: American Psychiatric Publishing.
Bouvard, M., & Cottraux, J. (2005). Protocoles et échelles d'évaluation en psychiatrie et en psychologie. Paris:
Masson.
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W.
JCR
Candilis, P. J., McLean, R. Y., Otto, M. W., Manfro, G. G., Worthington, J. J., 3rd, Penava, S. J., et al. (1999). Quality
42
of life in patients with panic disorder. Journal of
Nervous and Mental Disease, 187, 429-434.
Chambless, D. L., Caputo, G. C., Bright, P., & Gallagher, R.
(1984). Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the
agoraphobic cognitions questionnaire. Journal of
Consulting and Clinical Psychology, 52, 10901097.
VRET vs. CBT for PDA
(2007). Comparing acceptance and refusal rates of
virtual reality exposure vs. in vivo exposure by patients with specific phobias. CyberPsychology and
Behavior, 10, 722-724.
Garcia-Palacios, A., Hoffman, H. G., See, S. K., Tsai, A., &
Botella, C. (2001). Redefining therapeutic success
with virtual reality exposure therapy. CyberPsychology and Behavior, 4, 341-348.
Choi, Y. H., Vincelli, F., Riva, G., Wiederhold, B. K., Lee, J. H.,
& Park, K. H. (2005). Effects of group experiential
cognitive therapy for the treatment of panic disorder
with agoraphobia. CyberPsychology and Behavior, 8,
387-393.
Goodwin, R. D., Faravelli, C., Rosi, S., Cosci, F., Truglia, E.,
de Graaf, R., et al. (2005). The epidemiology of panic
disorder and agoraphobia in Europe. European Neuropsychopharmacology, 15, 435-443.
Coelho, C. M., Waters, A. M., Hine, T. J., & Wallis, G. (2009).
The use of virtual reality in acrophobia research and
treatment. Journal of Anxiety Disorders, 23, 563-574.
Gorini, A., & Riva, G. (2008). Virtual reality in anxiety disorders: the past and the future. Expert Review of Neurotherapeutics, 8, 215-233.
Côté, S., & Bouchard, S. (2008). Virtual reality exposure for
phobias. A critical review. Journal of Cybertherapy
and Rehabilitation, 1, 75-92.
Hamilton, M. (1959). The assessment of anxiety states by rating.
British Journal of Medical Psychology, 32, 50-55.
Côté, S., & Bouchard, S. (2009). Cognitive mechanisms underlying virtual reality exposure. CyberPsychology and
Behavior, 12, 121-129.
Cottraux, J., Bouvard, M., & Légeron, P. (1985). Méthodes et
échelles d'évaluation des comportements.Issy les
Moulineaux: Editions d'Application Psychotechniques.
Cottraux, J., Note, I. D., Cungi, C., Legeron, P., Heim, F., Chneiweiss, L., et al. (1995). A controlled study of cognitive
behaviour therapy with buspirone or placebo in panic
disorder with agoraphobia. British Journal of Psychiatry, 167, 635-641.
de Carvalho, M.R., Freire, R.C., & Nardi, A.E. (2010). Virtual
reality as a mechanism for exposure therapy. World
Journal of Biological Psychiatry, 11(2 Pt 2), 220-30.
Draper, J. V., Kaber, D. B., & Usher, J. M. (1999). Speculations
on the value of telepresence. CyberPsychology and
Behavior, 2, 349-362.
Freire, R.C., De Carvalho, M.R., Joffily, M., Zin, W.A., Nardi,
A.E. (2010). Anxiogenic properties of a computer
simulation for panic disorder with agoraphobia. Journal of Affective Disorder, 2010.
Furukawa, T. A., Watanabe, N., & Churchill, R. (2007). Combined psychotherapy plus antidepressants for panic
disorder with or without agoraphobia. Cochrane
Database of Systematic Reviews, CD004364.
Garcia-Palacios, A., Botella, C., Hoffman, H., & Fabregat, S.
Hamilton, M. (1960). A rating scale for depression. Journal of
Neurology Neurosurgery & Psychiatry, 23, 56-62.
Hoogduin, C., De Haan, E., & Schaap, C. (1989). The significance of patient-therapist relationship in the treatment
of obsessive-compulsive disorder. British Journal of
Clinical Psychology, 28, 185-186.
Jacob, R. G., Whitney, S. L., Detweiler-Shostak, G., & Furman,
J. M. (2001). Vestibular rehabilitation for patients
with agoraphobia and vestibular dysfunction: a pilot
study. Journal of Anxiety Disorders, 15, 131-146.
Jang, D., Ku, J., Shin, M., Choi, Y., & Kim, S. (2000). Objective
validation of the effectiveness of virtual reality psychotherapy. CyberPsychology and Behavior, 3, 369-374.
Landon, T. M., & Barlow, D. H. (2004). Cognitive-behavioral
treatment for panic disorder: current status. Journal
of Psychiatric Practice, 10, 211-226.
Lecrubier, Y., Sheehan, D. V., Weiller, E., Armorim, P., Bonora,
I., Sheehan, K. H., et al. (1997). The Mini International Neuropsychiatric Interview (MINI) a short diagnostic structured interview : reliability and validity
according to the CIDI. European Psychiatry, 12, 224231.
Marks, I., & Mathews, A. (1982). Brief standard self-rating for
phobic patients. Behavior Research and Therapy, 17,
263-267.
Mataix-Cols, D., Cowley, A. J., Hankins, M., Schneider, A., Bachofen, M., Kenwright, M., et al. (2005). Reliability
and validity of the work and social adjustment scale
JCR
Pelissolo et al.
43
in phobic disorders. Comprehensive Psychiatry, 46,
223-228.
Meyerbröker, K., Emmelkamp, P.M. (2010). Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depression &
Anxiety, 27, 933-44.
Robillard, G., Bouchard, S., Fournier, T., & Renaud, P. (2003).
Anxiety and presence during VR immersion: a comparative study of the reactions of phobic and non-phobic participants in therapeutic virtual environments
derived from computer games. CyberPsychology and
Behavior, 6, 467-476.
Mitte, K. (2005). A meta-analysis of the efficacy of psycho- and
pharmacotherapy in panic disorder with and without
agoraphobia. Journal of Affective Disorders, 88, 27-45.
Roy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G.,
Bystritsky, A., Katon, W., et al. (2005). A randomized
effectiveness trial of cognitive-behavioral therapy and
medication for primary care panic disorder. Archives
of General Psychiatry, 62, 290-298.
North, M., North, S., & Coble, J. (1996). Effectiveness of virtual
environment desensitization in the treatment of agoraphobia. Presence, 5, 346–352.
Ost, L. G., Thulin, U., & Ramnero, J. (2004). Cognitive behavior therapy vs exposure in vivo in the treatment of
panic disorder with agoraphobia. Behavior Research
and Therapy, 42, 1105-1127.
Otto, M. W., & Deveney, C. (2005). Cognitive-behavioral therapy
and the treatment of panic disorder: efficacy and strategies. Journal of Clinical Psychiatry, 66 Suppl 4, 28-32.
Parsons, T. D., & Rizzo, A. A. (2008). Affective outcomes of
virtual reality exposure therapy for anxiety and specific phobias: A meta-analysis. Journal of Behavior
Therapy and Experimental Psychiatry, 39, 250-261.
Powers, M. B., & Emmelkamp, P. M. (2008). Virtual reality exposure therapy for anxiety disorders: A meta-analysis.
Journal of Anxiety Disorders, 22, 561-569.
Price, M., & Anderson, P. (2007). The role of presence in virtual
reality exposure therapy. Journal of Anxiety Disorders, 21, 742-751.
Price, M., Anderson, P., Henrich, C. C., & Rothbaum, B. O.
(2008). Greater expectations: using hierarchical linear
modeling to examine expectancy for treatment outcome as a predictor of treatment response. Behavior
Therapy, 39, 398-405.
Pull, C. B. (2005). Current status of virtual reality exposure therapy in anxiety disorders: editorial review. Current
Opinion in Psychiatry, 18, 7-14.
Redfern, M. S., Furman, J. M., & Jacob, R. G. (2007). Visually
induced postural sway in anxiety disorders. Journal
of Anxiety Disorders, 21, 704-716.
Riva, G. (2008). From virtual to real body: virtual reality as embodied technology. Journal of Cybertherapy and Rehabilitation, 1, 7-35.
JCR
View publication stats
Shear, M. K., Houck, P., Greeno, C., & Masters, S. (2001). Emotion-focused psychotherapy for patients with panic
disorder. American Journal of Psychiatry, 158, 19931998.
Shear, M. K., Rucci, P., Williams, J., Frank, E., Grochocinski,
V., Vander Bilt, J., et al. (2001). Reliability and validity of the Panic Disorder Severity Scale: replication
and extension. Journal of Psychiatric Research, 35,
293-296.
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996). The
measurement of disability. International Clinical Psychopharmacology, 11 Suppl 3, 89-95.
Spielberger, C. (1983). State-trait Anxiety Inventory: A Comprehensive Bibliography. Palo Alto, CA: Consulting
Psychologists Press.
Viaud-Delmon, I., Ivanenko, Y. P., Berthoz, A., & Jouvent, R.
(2000). Adaptation as a sensorial profile in trait anxiety: a study with virtual reality. Journal of Anxiety
Disorders, 14, 583-601.
Viaud-Delmon, I., Warusfel, O., Seguelas, A., Rio, E., & Jouvent, R. (2006). High sensitivity to multisensory conflicts in agoraphobia exhibited by virtual reality.
European Psychiatry, 21, 501-508.
Vincelli, F., Anolli, L., Bouchard, S., Wiederhold, B. K., Zurloni, V., & Riva, G. (2003). Experiential cognitive
therapy in the treatment of panic disorders with agoraphobia: a controlled study. CyberPsychology and
Behavior, 6, 321-328.
Wiederhold, B., & Wiederhold, M. (2005). Virtual reality for
anxiety disorders. Advances in evaluation and treatment. Washington DC: American Psychological Association.